Based on our long-standing tradition as a family business, Medice Arzneimittel GmbH & Co. KG will play a significant role in shaping the future of medicine in the coming decade. The company plans be a leading global developer and provider of innovative, integrated and diverse healthcare solutions.

Revenue(RF), mln.USD
20
Staff(RF), 2021
8
Capital(RF), mln.USD
4
Assets(RF), mln.USD
9
The Company Statement

Very important, Neo-Angin and Nasic make big profits for Medice, pharmreg.ru and Items. Increased russia-driven revenue and profit in 2023 vs 2022. LLC "Medice" in Moscow is the local representative.

Website in Russian - About us
MEDICE, LLC - General Director Emelyanov Stanislav Viktorovich - TIN 7725497424
LLC "MEDICE" - Moscow - General Director Emelyanov S. V. – TIN 7725497424
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner